AMAG Pharmaceuticals Analysis
AMAG Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of AMAG Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what AMAG Pharmaceuticals is worth, separate from its market price. There are two main types of AMAG Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AMAG Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AMAG Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The AMAG Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AMAG Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. AMAG Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AMAG Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
AMAG |
AMAG Stock Analysis Notes
About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. AMAG Pharmaceuticals has Price/Earnings To Growth (PEG) ratio of 0.6. The entity recorded a loss per share of 6.77. The firm had not issued any dividends in recent years. AMAG Pharmaceuticals had 3:2 split on the 26th of September 1991. AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and womens health, and anemia management in the United States. As of November 12, 2020, AMAG Pharmaceuticals, Inc. operates as a subsidiary of Covis Group S. r.l. AMAG Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 440 people. For more info on AMAG Pharmaceuticals please contact William Heiden at 617 498-3300 or go to www.amagpharma.com.AMAG Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AMAG Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AMAG Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AMAG Pharmaceuticals is not yet fully synchronised with the market data | |
| AMAG Pharmaceuticals has some characteristics of a very speculative penny stock | |
| AMAG Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 300.12 M. Net Loss for the year was (231.62 M) with profit before overhead, payroll, taxes, and interest of 219.35 M. | |
| AMAG Pharmaceuticals currently holds about 168.9 M in cash with (26.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.86. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies |
AMAG Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 477.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AMAG Pharmaceuticals's market, we take the total number of its shares issued and multiply it by AMAG Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.AMAG Profitablity
AMAG Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase AMAG Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, AMAG Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AMAG Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AMAG Pharmaceuticals' profitability requires more research than a typical breakdown of AMAG Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (77.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (13.88) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $13.88.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AMAG Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AMAG Pharmaceuticals information on this page should be used as a complementary analysis to other AMAG Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in AMAG Stock
If you are still planning to invest in AMAG Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AMAG Pharmaceuticals' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |